Major Lipids, Apolipoproteins, and Risk of Vascular Disease
Top Cited Papers
Open Access
- 11 November 2009
- journal article
- research article
- Published by American Medical Association (AMA) in JAMA
- Vol. 302 (18) , 1993-2000
- https://doi.org/10.1001/jama.2009.1619
Abstract
Reliable assessment of the separate and joint associations of major blood lipids and apolipoproteins with the risk of vascular disease is important for the development of screening and therapeutic strategies.1,2 Expert opinion is divided about whether assessment of apolipoprotein AI (apo AI) and apolipoprotein B (apo B) should replace assessment of high-density lipoprotein cholesterol (HDL-C) and total cholesterol levels in assessment of vascular risk.3-5Keywords
This publication has 32 references indexed in Scilit:
- Lipoprotein(a) Concentration and the Risk of Coronary Heart Disease, Stroke, and Nonvascular MortalityJAMA, 2009
- The joint effects of apolipoprotein B, apolipoprotein A1, LDL cholesterol, and HDL cholesterol on risk: 3510 cases of acute myocardial infarction and 9805 controlsEuropean Heart Journal, 2009
- Correcting for multivariate measurement error by regression calibration in meta‐analyses of epidemiological studiesStatistics in Medicine, 2009
- Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive ProteinNew England Journal of Medicine, 2008
- Triglycerides and the Risk of Coronary Heart Disease: 10 158 Incident Cases Among 262 255 Participants in 29 Western Prospective StudiesYearbook of Pathology and Laboratory Medicine, 2008
- The Emerging Risk Factors Collaboration: analysis of individual data on lipid, inflammatory and other markers in over 1.1 million participants in 104 prospective studies of cardiovascular diseasesEuropean Journal of Epidemiology, 2007
- High-Density Lipoprotein as a Therapeutic TargetJAMA, 2007
- Fasting Compared With Nonfasting Triglycerides and Risk of Cardiovascular Events in WomenJAMA, 2007
- Nonfasting Triglycerides and Risk of Myocardial Infarction, Ischemic Heart Disease, and Death in Men and WomenJAMA, 2007
- Quantifying heterogeneity in a meta‐analysisStatistics in Medicine, 2002